ESWT for Acute and Chronic Soft Tissue Wounds

Wolfgang Schaden, M.D., Richard Thiele, M.D., Christine Kölpl, M.D., Michael Pusch, M.D., Aviram Nissan, M.D., Christopher E. Attinger, M.D., F.A.C.S., Mary E. Maniscalco-Theberge, M.D., F.A.C.S., George E. Peoples, M.D., F.A.C.S., Eric A. Elster, M.D., F.A.C.S., and Alexander Stojadinovic, M.D., F.A.C.S.

Nonhealing wounds are a major, functionally-limiting medical problem impairing quality of life for millions of people each year. Various studies report complete wound epithelialization of 48 to 56% over 30 to 65 d with different treatment modalities including ultrasound, topical rPDGF-BB, and composite acellular matrix. This is in contrast to comparison control patients treated with standard wound care, demonstrating complete epithelialization rates of 25 to 39%. Extracorporeal shock wave therapy (ESWT) may accelerate and improve wound repair. This study assesses the feasibility and safety of ESWT for acute and chronic soft-tissue wounds.

Click here to read more.

Related Posts